Japan could become one of the first countries in the world to end the HIV epidemic, says the president of Gilead Sciences Japan, Kennet Brysting. The idea for now could seem a little too ambitious, but it is not entirely unrealistic, given that the availability of medicines that can prevent transmission of HIV. Drugs are not the cure, but control over the spread of virus to the point where the disease is no longer a major public health threat.

What Is The Role Of Preventative HIV Medicines?

Gilead's have two key drugs, Truvada and lenacapavir. These two are playing a crucial role in prevention. Truvada is taken as a daily pill, while lenacapavir requires two injections per year. It can make the virus undetectable in infected individuals and prevent transmission to those who are not infected yet. In trials, lenacapavir showed 100% efficacy in preventing HIV infections. This is why it is describe as "almost a vaccine".

In 2024, Japan also approved Truvada for HIV prevention, but the country has yet to approve lenacapavir for the same. Until now, people in Japan had been importing generic versions of Truvada or purchasing it from clinics that source it from overseas.

HIV In Japan

Up until now, Japan reported around 25,000 HIV infections, whereas 669 new cases were reported in 2023. For seven consecutive years, the number of new infections remained under 1,000. The downward trend thus shows that the virus has been controlled, however, getting to zero new infections remains the ultimate goal.

Brysting too acknowledged that simply having effective drug is not enough. What is important is to have a proper implementation, access and healthcare support to make sure that these treatments are widely available and effective.

What Are The Challenges In Implementation?

The biggest challenges is testing rates. There is a need to increase testing rates. At this very moment, around 86% people infective with Japan have been tested, but the goal is to increase it up to 95%, with an ideal goal of 100%. Without widespread testing, many infected people may not even know that they are infected and it could transmit the virus.

Another measure issue is the cost of preventative medication. While Japan's health insurance covers treatments for diseases, it does not cover preventative drugs. Those who purchase Truvada for prevention, pay around $470 per month. Some clinics in Tokyo offer generic alternatives too, which is cheaper, but they are not ideal.

Better Healthcare Support

Brysting expressed concern that individuals importing medications might not be consulting doctors regularly, which is essential for monitoring HIV status and overall health. Truvada users need to be tested for HIV initially and every three months, along with screenings for other infections and kidney function checks. Without proper medical supervision, there is a risk of misuse and inadequate protection.

Gilead is in discussions with Japanese authorities to improve access and insurance coverage for Truvada, and progress is being made. Japan has shown efficiency in approving critical medicines, as seen during the COVID-19 pandemic when Gilead’s remdesivir was approved in just three days.

What Is The Way Ahead?

Gilead at this moment is not only focused on HIV and hepatitis C, but also expanding into oncology with innovative treatments like CAR-T cell therapy, which strengthens a patient's immune system to fight cancer.

However, Japan’s strict approval processes can slow down drug availability. Phase 3 clinical trials often need to be conducted within the country, and Japan tends to approve medicines much later than other regions. For instance, Truvada was approved for prevention in Japan 12 years after the U.S. and nearly 20 years after its approval for treatment. inancial factors also play a role. The Japanese government adjusts drug prices annually, often reducing them, which can make long-term investment challenging for pharmaceutical companies.

Billy Connolly Parkinson's Disease: Martin Compston, Sottish actor and former footballer praised Sir Billy Connolly, actor, comedian and musician, for handling his Parkinson's disease in an "incredibly brave" way.

The 83-year-old comedian was diagnosed in 2013, and five years post that, in 2018, he announced his retirement. Compston who is also co-host of Hoolie In The Hydro, said that the Scottish comedian battled the disease "with a smile on his face and cracking jokes that only Billy can."

He said, "Obviously, Billy’s been battling Parkinson’s but he’s been battling incredibly bravely and again he’s done it with a smile on his face and cracking jokes that only Billy can. I’m hoping he’s with us for a long time to come.”

Billy Connolly Health Update

In 2024, Billy made an admission about death amid his ongoing health struggles. In his 2023 autobiography, he mocked the "exaggerated" reports of his "demise". However, the actor-comedian said that he has maintained a positive outlook about his health and that he does not feel "close to death".

In an interview with The Mirror, he said that he remembers the day when he was told he had Parkinson's was the same day he was diagnosed with prostate cancer. "Yes, it was a funny week I had. On the Monday, I had hearing aids. On the Tuesday I got pills for heartburn, which I have to take all the time, and on the Wednesday, I got news that I had prostate cancer and Parkinson’s."

He shared that the best way to deal with such a news is to start thinking about the next step, which is the treatment. "You just have to think. Don't think you are being badly treated [by life] or you have the bad pick of the straws. You are one of millions. Just behave yourself and relax."

Connolly got the all-clear from prostate cancer after receiving treatment, reported the Independent.

Read: Can You Detect Dementia With An Eye Test?

As far as Parkinson's is concerned, his wife, Pamela Stephenson had said that her husband had the "most significant" symptom of the disease, which was a "couple of serious falls" that happened after his balance deteriorated due to Parkinson's.

Talking to Guardian, Billy said, "Recently I've noticed a deterioration in my balance. That was never such a problem before, but in the last year that has come and it has stayed. For some reason, I thought it would go away because a lot of the symptoms have come and gone away."

Prostate Cancer And Parkinson's Disease In Men Aged 40-50

The John Hopkins Medicine recommends screening for prostate cancer at age 55, and start their PSA screening between ages 40 to 54.

What Is Prostate Cancer? Prostate cancer is the most commonly diagnosed cancer in men and the second leading cause of cancer-related deaths in the United States. In many cases, it grows slowly, and detecting or treating it before symptoms appear may not always improve health outcomes or extend life. Learn more about prostate cancer, including screening, prevention, treatment options, research, and key statistics.

The National Institute of Neurological Disorders and Stroke says that while an average age of onset of Parkinson's disease in a person is in early to mid 60s, there could be some people who may have the disease before the age of 50.

In fact, a 2019 study in the Journal of Parkinson's Disease notes that while the mortality rate of Parkinson's disease is higher in women, risk of developing it is twice as high in men than women.

What Is Parkinson's Disease? Parkinson’s disease is a slowly progressing disorder that affects movement and the nervous system. It develops when certain nerve cells in the brain weaken, become damaged, or die. As a result, people may experience tremors, stiffness, slowed movement, and balance problems. Over time, these symptoms can make everyday activities like walking, talking, and simple tasks more difficult.

Three children from Ottawa and Eastern Ontario have died due to flu-related complications over the past two weeks, as an unusually early and aggressive flu season grips the region. Health officials have confirmed that the cases are linked to Influenza A, a strain currently circulating widely and affecting children more severely than usual, as per CTV news.

The children were between five and nine years old. Authorities have not released further personal details about the two Ottawa cases and one case from Eastern Ontario.

What Is Influenza A?

Influenza A is a fast-spreading respiratory virus responsible for seasonal flu outbreaks and, at times, global pandemics. It changes quickly through genetic shifts, which makes new strains harder to predict and control. The virus is grouped based on surface proteins called hemagglutinin and neuraminidase, with H1N1 and H3N2 among the most common strains in circulation. It spreads mainly through coughs, sneezes, or close contact and often comes on suddenly, causing fever, cough, body pain, and extreme tiredness. In some cases, it can lead to serious complications, especially in vulnerable groups.

Influenza A: Health Officials Call Deaths a Serious Warning

Public health leaders from Ottawa and Eastern Ontario described the deaths as a troubling reminder of how dangerous the flu can be, especially for children.

“This highlights that influenza is not always a mild illness. It can lead to serious complications that require hospitalization,” medical officers of health from both regions said in a joint statement issued on Monday, as per CTV News.

Influenza A: Child Flu Deaths Rare but Not Unprecedented in Canada

While flu-related deaths among children are uncommon in Canada, they are not unheard of. During the last severe flu season in 2022, two children in Ottawa died due to influenza.

Most flu-related deaths in Canada occur among older adults. Of the estimated 3,500 flu deaths reported nationwide each year, roughly 90 percent involve people over the age of 65. However, experts say the current Influenza A strain is behaving differently.

Influenza A Hitting Children Hard This Season

The strain of Influenza A currently circulating has been linked to a sharp rise in severe pediatric flu cases globally. Health officials say the cluster of three child deaths within such a short period, and within a relatively small geographic area, is highly unusual.

This unusual pattern prompted the regional coroner to alert public health authorities after three sudden, unexpected child deaths tested positive for Influenza A.

“It’s rare for the coroner to reach out like this,” said Dr. Trevor Arnason, Ottawa’s medical officer of health. “But this season has been particularly severe.”

Influenza A: Hospitals Strained as Pediatric Cases Rise

CHEO, Ottawa’s children’s hospital, has reported high numbers of children falling seriously ill with the flu since November. Hospitalizations have continued to rise through early December.

Last week, CHEO issued an urgent request asking family doctors to extend clinic hours and assist at the hospital’s Kids Come First clinic to help manage patient volumes.

Hospital officials have also noted that many children arriving at the emergency department with severe flu symptoms had not been vaccinated.

Influenza A: Strong Push for Flu Vaccination as Cases Surge

Public health officials, including Ontario’s Chief Medical Officer of Health Dr. Kieran Moore, are urging everyone aged six months and older to get vaccinated as soon as possible.

Dr. Arnason and Dr. Paul Roumeliotis, medical officer of health and CEO of the Eastern Ontario Health Unit, stressed that vaccination is especially important for children this season.

Influenza A: Vaccine Still Effective Despite Strain Mutation

Some people have expressed concern after reports suggested this year’s flu vaccine is not a perfect match for the circulating Influenza A strain. Health officials clarified that while the virus has mutated slightly since circulating in the southern hemisphere, the vaccine still offers meaningful protection.

“The flu vaccine may not always prevent infection, but it significantly reduces the risk of severe illness, hospitalization, and complications,” officials said. They added that the vaccine takes about two weeks to become fully effective, making early vaccination crucial ahead of the holiday season, when virus spread typically increases.